Cargando…
Personalized treatment for advanced colorectal cancer: KRAS and beyond
Targeted therapies have improved the survival of patients with advanced colorectal cancer (CRC). However, further improvements in patient outcomes may be gained by the development of predictive biomarkers in order to select individuals who are most likely to benefit from treatment, thus personalizin...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839845/ https://www.ncbi.nlm.nih.gov/pubmed/24294007 http://dx.doi.org/10.2147/CMAR.S35025 |